Afficher la couverture 'The global impact of SARS-CoV-2 in 181 people with cystic fibrosis | Mcclenaghan, Elliot' en grand format
/5

0 avis

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Archive ouverte

Mcclenaghan, Elliot | Cosgriff, Rebecca | Brownlee, Keith | Ahern, Susannah | Burgel, Pierre-Régis | Byrnes, Catherine | Colombo, Carla | Corvol, Harriet | Cheng, Stephanie | Daneau, Géraldine | Elbert, Alexander | Faro, Albert | Goss, Christopher | Gulmans, Vincent | Gutierrez, Hector | de Monestrol, Isabelle | Jung, Andreas | Justus, Lutz Nährlich | Kashirskaya, Nataliya | Marshall, Bruce | Mckone, Edward | Middleton, Peter | Mondejar-Lopez, Pedro | Pastor-Vivero, M Dolores | Padoan, Rita | Rizvi, Samar | Ruseckaite, Rasa | Salvatore, Marco | Stephenson, Anne | Filho, Luiz Vicente R da Silva | Melo, Joel | Zampoli, Marco | Carr, Siobhán

Edité par CCSD ; Elsevier -

International audience. With the growing SARS-CoV-2 pandemic, we need to better understand its impact in specific patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 post-transplant) from 19 countries diagnosed with SARS-CoV-2 prior to 13 June 2020. Infection with SARS-CoV-2 appears to exhibit a similar spectrum of outcomes to that seen in the general population, with 11 people admitted to intensive care (7 post-transplant), and 7 deaths (3 post-transplant). A more severe clinical course may be associated with older age, CF-related diabetes, lower lung function in the year prior to infection, and having received an organ transplant. Whilst outcomes in this large cohort are better than initially feared overall, possibly due to a protective effect of the relatively younger age of the CF population compared to other chronic conditions, SARS-CoV-2 is not a benign disease for all people in this patient group.

Suggestions

Du même auteur

COVID-19 vaccine prioritisation for people with cystic fibrosis

Archive ouverte | Carr, Siobhán | CCSD

International audience. Cystic fibrosis (CF) is a rare genetic disease that affects several organs, but lung disease is the major cause of morbidity and mortality. The gene responsible for CF, the CFTR (Cystic Fibro...

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

Archive ouverte | Carr, Siobhán | CCSD

International audience. Background: This international study aimed to characterise the impact of acute SARS-CoV-2 infection in people with cystic fibrosis and investigate factors associated with severe outcomes. Met...

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

Archive ouverte | Cosgriff, Rebecca | CCSD

International audience. Information is lacking on the clinical impact of the novel coronavirus, SARS-CoV-2, on people with cystic fibrosis (CF). Our aim was to characterise SARS-CoV-2 infection in people with cystic...

Chargement des enrichissements...